ES2699001T3 - Nuevo compuesto antibacteriano de oxazolidinona - Google Patents

Nuevo compuesto antibacteriano de oxazolidinona Download PDF

Info

Publication number
ES2699001T3
ES2699001T3 ES14860707T ES14860707T ES2699001T3 ES 2699001 T3 ES2699001 T3 ES 2699001T3 ES 14860707 T ES14860707 T ES 14860707T ES 14860707 T ES14860707 T ES 14860707T ES 2699001 T3 ES2699001 T3 ES 2699001T3
Authority
ES
Spain
Prior art keywords
compound
ppm
formula
methyl
oxooxazolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14860707T
Other languages
English (en)
Spanish (es)
Inventor
Raghu Mitra Alla
Ajay Kumar Dubey
Srinivas Reddy Mallepalli
Ramakrishna Reddy Pongilati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lee Pharma Ltd
Original Assignee
Lee Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lee Pharma Ltd filed Critical Lee Pharma Ltd
Application granted granted Critical
Publication of ES2699001T3 publication Critical patent/ES2699001T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES14860707T 2013-11-08 2014-07-28 Nuevo compuesto antibacteriano de oxazolidinona Active ES2699001T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN5063CH2013 2013-11-08
IN2254CH2014 2014-05-05
PCT/IN2014/000497 WO2015068173A1 (en) 2013-11-08 2014-07-28 Novel oxazolidinone antibacterial compound

Publications (1)

Publication Number Publication Date
ES2699001T3 true ES2699001T3 (es) 2019-02-06

Family

ID=53040992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14860707T Active ES2699001T3 (es) 2013-11-08 2014-07-28 Nuevo compuesto antibacteriano de oxazolidinona

Country Status (6)

Country Link
US (1) US9573910B2 (cg-RX-API-DMAC7.html)
EP (1) EP3065740B1 (cg-RX-API-DMAC7.html)
JP (1) JP6286536B2 (cg-RX-API-DMAC7.html)
CN (1) CN105705147B (cg-RX-API-DMAC7.html)
ES (1) ES2699001T3 (cg-RX-API-DMAC7.html)
WO (1) WO2015068173A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117597337A (zh) * 2021-05-03 2024-02-23 迪斯库瓦有限公司 抗菌化合物的制备方法
CN115707685A (zh) * 2021-08-20 2023-02-21 中国石油化工股份有限公司 一种制备胺-环氧卤丙烷聚合单体的方法及产物和系统
CN114230547A (zh) * 2021-12-29 2022-03-25 江苏广域化学有限公司 取代苯甲醛缩醇的合成方法
CN116919954A (zh) * 2023-05-22 2023-10-24 成都大学 噁唑烷酮类化合物在制备抑制细菌群体感应的药物中的应用
CN118063452A (zh) * 2024-02-27 2024-05-24 山东大学 一种苯并噻唑或苯并噁唑的衍生物及其制备方法和应用
CN118515624B (zh) * 2024-04-29 2025-01-24 聊城金歌合成材料有限公司 一种含三氟甲基多取代恶唑烷-4-酮的合成方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CA2318969A1 (en) * 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
NZ522990A (en) 2000-06-05 2003-08-29 Dong A Pharm Novel oxazolidinone derivatives and a process for the preparation thereof
CN1155585C (zh) * 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
EP2141161A1 (en) * 2008-07-01 2010-01-06 Ferrer Internacional, S.A. 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents
EP2163547A1 (en) * 2008-09-16 2010-03-17 Unión Químico Farmacéutica, S.A. (UQUIFA) Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof
WO2015068171A1 (en) 2013-11-08 2015-05-14 Lee Pharma Limited Novel oxazolidinone compounds

Also Published As

Publication number Publication date
JP2016535039A (ja) 2016-11-10
CN105705147A (zh) 2016-06-22
JP6286536B2 (ja) 2018-02-28
US20160272597A1 (en) 2016-09-22
EP3065740A1 (en) 2016-09-14
EP3065740A4 (en) 2017-04-19
US9573910B2 (en) 2017-02-21
WO2015068173A1 (en) 2015-05-14
CN105705147B (zh) 2019-06-28
EP3065740B1 (en) 2018-08-22

Similar Documents

Publication Publication Date Title
RU2569307C1 (ru) Азотсодержащие соединения и их применение
CA3129741C (en) Compounds and methods of treating infections
KR101401658B1 (ko) 진세노사이드 컴파운드 ｋ 또는 이의 유도체로 된 항균제
WO2005009336A2 (en) Antibacterial methods and compositions
BR112017010132B1 (pt) Combinações e seus usos no tratamento de infecções bacterianas resistentes
JP6286536B2 (ja) 新規オキサゾリジノン抗菌化合物
JP6142076B2 (ja) 抗微生物性増強剤
US20160220568A1 (en) Antimicrobial Compounds and Methods of Making and Using the Same
UA105775C2 (uk) Похідні рифаміцину
US11014891B2 (en) Reduction-triggered antibacterial sideromycins
CN107106533B (zh) 用于治疗微生物感染的增效组合物
JP2021516230A (ja) 新規の抗マイコバクテリア複素環式アミド
CN116898840A (zh) 抗微生物组合物、医药组合物及其用途
JP6626516B2 (ja) 抗菌組成物及び方法
EP3448865A1 (en) Lipophosphonoxins of second generation, and their use
JP2016535038A (ja) 抗菌剤を含む医薬品組成物
ES2694028T3 (es) Régimen de tratamiento para compuesto de tiacumicina
US20260041683A1 (en) Compounds with Anti-Acinetobacter Baumannii Activity
ES2389070B1 (es) Derivados de policétidos dibenzofuránicos prenilados y su aplicación para el tratamiento de enfermedades infecciosas, parasitarias y tumores.
CN101326157A (zh) 二苯基脲衍生物
JP2014530908A (ja) 細菌性感染症の治療のための医薬組成物及びキット
Vitnik et al. Improved synthesis and in vitro study of antimicrobial activity of α, β-unsaturated and α-bromo carboxylic acids
CN121057579A (zh) 浮游细菌代谢的失调
JP2017508769A (ja) セフェピムまたはスルバクタムを含む医薬組成物
MX2008007478A (es) Derivados de difenilurea